Think Surgical, Inc. announced a private placement of 15,000,000 shares of other stock at $4 per share for gross proceeds of $60,000,000 on October 13, 2014. The face value of the shares to be issued is $0.0001 per share. The transaction will include participation from existing investors. Each existing investor will receive 0.3219817 of new share for 1 existing share held by them. The shares hold a dividend payment from January 01, 2014 onwards. The company announced that the transaction has been approved by the board of directors of Curexo Inc. The subscription period for the shares starts from October 13, 2014 and end on November 10, 2014. The company had common stock of 36,111,823 shares and other stock of 10,474,672 shares before the capital increase. The company had total assets worth KRW 10,882,064,310 ($9,890,720) in 2013. The conversion was made through www.oanda.com on October 13, 2014.

On November 11, 2014, the transaction has been approved by the board of directors of Curexo Inc.

On November 17, 2014, the company has amended the terms of the transaction. The company now will issue 30,000,000 series C-1 preferred shares at a price of $4 per share for gross proceeds of $120,000,000 in the transaction. The shares carry non-cumulative, and participating fixed dividend value of $0.32 per share. The shares are non-redeemable. The shares will be convertible into common shares at a fixed conversion price of $4 per share.

On December 9, 2014, the company has issued 817,617 series C-1 preferred shares at $4 price per share for gross proceeds of $3,270,468 in its first tranche. The company had 46,586,495 shares outstanding before the transaction. The company had total liabilities of KRW 1,040,000,000 ($932,777); total stockholders' equity of KRW 9,842,000,000 ($8,827,300); capital of KRW 4,000,000 ($3,587.60); sales revenue of KRW 1,688,000,000 ($1,513,970); and net loss of KRW 13,651,000,000 ($12,243,600) on December 31, 2013. The conversion was made through www.oanda.com on November 25, 2014.

On October 29, 2016, the transaction will include participation from the existing shareholders of the company including Curexo Inc. The company will issue 0.2423643 new shares for every existing share in the company. The subscription period for the shares will commence and end on October 31, 2016 and November 16, 2016 respectively. The payment date for the shares is expected on December 9, 2016. The transaction was approved by the board of directors of Curexo Inc.

On November 16, 2016, the company announced that Curexo Inc will subscribe for 500,000 series C-1 preferred shares in the transaction. The company reported total assets of KRW 32,768,000,000 ($27,869,200), total liabilities of KRW 2,263,000,000 ($1,924,680), total capital of KRW 30,505,000,000 ($25,944,500), capital of KRW 6,000,000 ($5,103), sales of KRW 279,000,000 ($237,289), and net profit of KRW -25,518,000,000 ($-21,703,000) for the year ended December 31, 2015.

On December 2, 2016, the company has amended the terms of the transaction. The company now will issue 45,000,000 series C-1 preferred shares for gross proceeds of $180,000,000 in the transaction.